| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 266, Issue 1 E17-E25, Copyright © 1994 by American Physiological Society
ARTICLES |
Y. J. Yang, I. D. Hope, M. Ader and R. N. Bergman
Department of Physiology and Biophysics, University of Southern California, Los Angeles 90033.
Insulin action in vivo is determined by both transendothelial insulin transport (TET) across the capillary and subsequent insulin binding and postreceptor events. To examine TET under non-steady-state conditions, we performed intravenous glucose tolerance tests (IVGTT; 0.3 g/kg; n = 7) on conscious dogs. At basal, insulin in lymph was only 53 +/- 7% of plasma insulin (P < 0.001), whereas lymph glucose exceeded plasma levels (109 +/- 4 vs. 104 +/- 4 mg/dl, respectively; P < 0.02). On injection, dynamics of glucose in plasma and lymph were similar, suggesting rapid equilibration of glucose between compartments. In contrast, insulin appearance in lymph was delayed relative to plasma (5.1 +/- 1.3 vs. 2 +/- 0 min), peaked later (21 +/- 2 vs. 8 +/- 2 min), attained peak value of only 52 +/- 6% of plasma insulin (range, 35-76%), and remained lower than plasma insulin throughout the IVGTT (P < 0.05 or better). Minimal model-derived insulin sensitivity (SI) averaged 3.55 +/- 0.75 x 10(-4) min-1/(microU/ml). There was a strong linear relationship between lymph insulin and its effect on glucose disappearance [X(t), r = 0.95 +/- 0.01]. Determination of the relative contributions of TET and post-TET insulin-sensitive processes to overall SI revealed that cellular sensitivity to interstitial insulin dominated (r2 = 0.55), but was not the exclusive determinant of, overall SI, as insulin transport was also important (r2 = 0.21). TET is a previously unrecognized contributor to SI in vivo.
This article has been cited by other articles:
|
|
 |
|
  R. C. Boston and P. J. Moate A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1140 - R1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bodenlenz, L. A. Schaupp, T. Druml, R. Sommer, A. Wutte, H. C. Schaller, F. Sinner, P. Wach, and T. R. Pieber Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E296 - E300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Gavin, H. W. Stallings III, K. A. Zwetsloot, L. M. Westerkamp, N. A. Ryan, R. A. Moore, W. E. Pofahl, and R. C. Hickner Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans J Appl Physiol, January 1, 2005; 98(1): 315 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E Plante, M. Perreault, A. Lanthier, A. Marette, and P. Maheux Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model Cardiovasc Res, October 1, 2003; 59(4): 963 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E25 - E30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sjostrand, S. Gudbjornsdottir, A. Holmang, L. Lonn, L. Strindberg, and P. Lonnroth Delayed Transcapillary Transport of Insulin to Muscle Interstitial Fluid in Obese Subjects Diabetes, September 1, 2002; 51(9): 2742 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Cherrington, D. Sindelar, D. Edgerton, K. Steiner, and O. P. McGuinness Physiological Consequences of Phasic Insulin Release in the Normal Animal Diabetes, February 1, 2002; 51(90001): S103 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rebrin, G. M. Steil, W. P. van Antwerp, and J. J. Mastrototaro Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E561 - E571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. McArthur, D. You, K. Klapstein, and D. T. Finegood Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E739 - E746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sjostrand, A. Holmang, and P. Lonnroth Measurement of interstitial insulin in human muscle Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E151 - E154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Hickey, C. J. Tanner, D. S. O'Neill, L. J. Morgan, G. L. Dohm, and J. A. Houmard Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo J Appl Physiol, September 1, 1997; 83(3): 718 - 722. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
